Insider · CIK 0001846675
Kwaku Temeng
Files at CLB (Core Laboratories Inc. /DE/). First filing -, latest -.
In brief
Kwaku Temeng files SEC Form 4 as director at CLB (Core Laboratories Inc. /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kwaku Temeng has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | MOption exercise Common Stock | +8,069 | $0.00 | $0 | 33,597 | Apr 7, 2026 |
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | AGrant or award Restricted Sharesderivative | +7,895 | $0.00 | $0 | 7,895 | Apr 7, 2026 |
| Apr 1, 2026 | CLB Core Laboratories Inc. /DE/ | MOption exercise Restricted Sharesderivative | -8,069 | $0.00 | $0 | 0 | Apr 7, 2026 |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | MOption exercise Common Stock | +9,317 | $0.00 | $0 | 25,528 | Apr 2, 2025 |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | AGrant or award Restricted Sharesderivative | +8,069 | $0.00 | $0 | 8,069 | Apr 2, 2025 |
| Apr 1, 2025 | CLB Core Laboratories Inc. /DE/ | MOption exercise Restricted Sharesderivative | -9,317 | $0.00 | $0 | 0 | Apr 2, 2025 |
Questions about Kwaku Temeng
Answered from the filings on this page, as of the latest one.
Is Kwaku Temeng buying or selling?
Kwaku Temeng has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kwaku Temeng's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kwaku Temeng has 0.
Where does Kwaku Temeng file Form 4?
Kwaku Temeng has filed Form 4 at CLB (Core Laboratories Inc. /DE/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.